Font Size: a A A
Keyword [Preserved Ejection Fraction]
Result: 21 - 40 | Page: 2 of 10
21. The Disscussion On The Progress Of The Diagnosis And Treatment Of The Heart Failure With Preserved Ejection Fraction
22. A Clinical Study Of Echocardiographic Grading Of Left Ventricular Diastolic Function In Heart Failure With Preserved Ejection Fraction
23. Plasma Soluble ST2 Level And Its Prognostic Value In Patients With Heart Failure With Preserved Ejection Fraction
24. Clinical Studies On SST2 And Cystatin C In The Diagnosis And Prognosis Of Heart Failure Patients With Preserved Ejection Fraction
25. Based On The Study Of Myocardial Cell Calcium Homeostasis, Yiqihuoxue Drugs Prevent And Treat Diastolic Heart Failure
26. The Diagnostic Value Of Plasma BNP And Risk Factors For The Heart Failure With Preserved Ejection Fraction
27. The Diagnostic Value Of Plasma N-Terminal Pro-brain Natriuretic Neptide In The Heart Failure With Preserved Ejection Fraction
28. Effect Of Recombinant Human Brain Natriuretic Peptide On Cardiac Function In Patients With Heart Failure With Preserved Ejection Fraction
29. Clinical Study Of Heart Failure With Preserved Ejection Fraction Treated With Yiqi-yangyin-tongluo Treatment
30. The Protective Mechanism Of Qiliqiangxin By Activating PPAR-Gamma On Cardiac Remodeling
31. Biomarkers For Characterization Of Heart Failure-distinction Of Heart Failure With Preserved And Reduced Ejection Fraction
32. Interatrial Dyssynchrony In Heart Failure With Preserved Ejection Fraction Using Two-Dimensional Speckle Tracking Imaging
33. Speckle Tracking Imaging In Evaluating Of Left Ventricular Remodeling After Acute Anterior Myocardial Infarction In Patients With Preserved Ejection Fraction
34. Clinical Study Of Noninvasive Hemodynamic Assessment In Patients With Heart Failure With Preserved Ejection Fraction
35. Correlation Between Monocyte To HDL Cholesterol Ratio And B-type Natriuretic Peptide In Patients With Preserved Ejection Fraction Heart Failure And 2 Type Diabetes Mellitus
36. The Analysis Of Clinical Characteristics And Prognosis Of Hospitalized Patients With Heart Failure With Mid-range Ejection Fraction
37. Efficacy And Safety Of Mineralocorticoid Receptor Antagonists In The Treatment Of Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
38. Vitamin B12 Deficiency In Heart Failure Patients With Preserved Ejection Fraction
39. The Effect Of Spinal Cord Stimulation On Heart Failure With Preserved Ejection Fraction
40. The Value Of Neprilysin In Cardiac Insufficiency With Preserved Ejection Fraction-A Pilot Study
  <<First  <Prev  Next>  Last>>  Jump to